Concepedia

Madeleine L. Craze

ML

Statistics

Publications

20

Citations

976

H-Index

18

Active since

2012

Affiliations

University of Nottingham(Current)

Nottingham University Hospitals NHS Trust

Nottingham City Hospital

University of Westminster

University of Tripoli

Madeleine L. Craze is an author at University of Nottingham specializing in molecular oncology, oncology, and medicine.

ORCID

Publications per year

2012–2025

20

Publications

20

The amino acid transporter SLC7A5 confers a poor prognosis in the highly proliferative breast cancer subtypes and is a key therapeutic target in luminal B tumours

Rokaya El Ansari, Madeleine L. Craze, Islam M. Miligy et al. · Breast Cancer Research · 2018 · 142 citations · Full text

, , +17

Increased expression of glutamine transporter SNAT2/SLC38A2 promotes glutamine dependence and oxidative stress resistance, and is associated with worse prognosis in triple-negative breast cancer

Matteo Morotti, Christos E. Zois, Rokaya El Ansari et al. · British Journal of Cancer · 2020 · 132 citations · Full text

, , +5

MYC regulation of glutamine–proline regulatory axis is key in luminal B breast cancer

Madeleine L. Craze, Hayley Cheung, Natasha Jewa et al. · British Journal of Cancer · 2017 · 96 citations · Full text

, , +17

The multifunctional solute carrier 3A2 (SLC3A2) confers a poor prognosis in the highly proliferative breast cancer subtypes

Rokaya El Ansari, Madeleine L. Craze, Maria Diez‐Rodriguez et al. · British Journal of Cancer · 2018 · 65 citations · Full text

, , +16

Glutamate dehydrogenase (GLUD1) expression in breast cancer

Madeleine L. Craze, Rokaya El Ansari, Mohammed A. Aleskandarany et al. · Breast Cancer Research and Treatment · 2018 · 62 citations · Full text

, , +12

1–5 of 20